Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas
Clinical trial NCT01788189 · COMPLETED
Trial details
- NCT number
- NCT01788189
- Sponsor
- University Hospital, Essen
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2020-02-20
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.